Profil
David W.
Mueller was the Chief Executive Officer of Clear Vascular, Inc. and the Director of Cell Robotics International, Inc. from 2002 to 2005.
Ehemalige bekannte Positionen von David W. Mueller
Unternehmen | Position | Ende |
---|---|---|
Cell Robotics International, Inc.
Cell Robotics International, Inc. Medical SpecialtiesHealth Technology Cell Robotics International, Inc. manufactures, markets and sells laser-based medical devices and scientific research instruments. The firm's medical products include the Lasette(R) line of laser lancing equipment and accessories for capillary blood sampling. Its scientific products include laser microscopy equipment featuring the LaserScissors(R) and LaserTweezers(R) instruments. The company also develops proprietary medical laser for aesthetic applications. Cell Robotics International was founded on September 28, 1988 and is headquartered in Albuquerque, NM. | Direktor/Vorstandsmitglied | 24.05.2005 |
Clear Vascular, Inc.
Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Clear Vascular, Inc. develops radionuclide products for multiple clinical applications. The firm has developed an injectable, targeted radiopharmaceutical agent, Tin-Annexin, for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque. It is a private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. The company was founded by Gilbert R. Gonzales in 2005 and is headquartered in Austin, TX. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Clear Vascular, Inc.
Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Clear Vascular, Inc. develops radionuclide products for multiple clinical applications. The firm has developed an injectable, targeted radiopharmaceutical agent, Tin-Annexin, for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque. It is a private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. The company was founded by Gilbert R. Gonzales in 2005 and is headquartered in Austin, TX. | Health Technology |
Cell Robotics International, Inc.
Cell Robotics International, Inc. Medical SpecialtiesHealth Technology Cell Robotics International, Inc. manufactures, markets and sells laser-based medical devices and scientific research instruments. The firm's medical products include the Lasette(R) line of laser lancing equipment and accessories for capillary blood sampling. Its scientific products include laser microscopy equipment featuring the LaserScissors(R) and LaserTweezers(R) instruments. The company also develops proprietary medical laser for aesthetic applications. Cell Robotics International was founded on September 28, 1988 and is headquartered in Albuquerque, NM. | Health Technology |